Innoveren Scientific Inc. Stock price
Equities
IVRN
US4041243076
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.033 USD | +17.86% | -26.67% | -71.55% |
Financials (USD)
Sales 2021 | 1.61M | Sales 2022 | 453K | Capitalization | 1.62M |
---|---|---|---|---|---|
Net income 2021 | -4M | Net income 2022 | -10M | EV / Sales 2021 | 7.95 x |
Net Debt 2021 | 3.52M | Net Debt 2022 | 3.92M | EV / Sales 2022 | 12.2 x |
P/E ratio 2021 |
-1.73
x | P/E ratio 2022 |
-0.08
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 35.62% |
1 day | +17.86% | ||
1 week | -26.67% | ||
Current month | -16.88% | ||
1 month | +37.50% | ||
3 months | -82.45% | ||
6 months | -90.23% | ||
Current year | -71.55% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 19-01-07 | |
Jeremy Daniel
DFI | Director of Finance/CFO | 48 | 19-02-03 |
Tanya Rhodes
CTO | Chief Tech/Sci/R&D Officer | 64 | 20-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 22-01-16 | |
Chief Executive Officer | 53 | 19-01-07 | |
William E. Horne
BRD | Director/Board Member | 70 | 18-10-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.033 | +17.86% | 300,279 |
24-03-27 | 0.028 | -0.25% | 330,410 |
24-03-26 | 0.0281 | +0.25% | 339,952 |
24-03-25 | 0.028 | -6.67% | 59,465 |
24-03-22 | 0.03 | -33.33% | 130,479 |
Delayed Quote OTC Markets, March 28, 2024 at 02:37 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-71.55% | 85.29K | |
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.69% | 46.84B | |
+4.66% | 42.64B | |
+15.12% | 29.09B |